Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections

NCT00001911 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Atypical Mycobacterium Infection

Interventions

DRUG: Interleukin-12

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)